• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function

tetano

Editor, Senior Moderator
J Immunol. 2019 Aug 19. pii: ji1801648. doi: 10.4049/jimmunol.1801648. [Epub ahead of print]
[h=1]Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.[/h] Wagstaffe HR[SUP]1[/SUP], Pickering H[SUP]2[/SUP], Houghton J[SUP]2[/SUP], Mooney JP[SUP]1,[/SUP][SUP]3[/SUP], Wolf AS[SUP]1,[/SUP][SUP]4[/SUP], Prevatt N[SUP]2[/SUP], Behrens RH[SUP]2[/SUP], Holland MJ[SUP]2[/SUP], Riley EM[SUP]1,[/SUP][SUP]3[/SUP], Goodier MR[SUP]5[/SUP].
[h=3]Author information[/h] 1 Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom. 2 Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom. 3 The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, United Kingdom; and. 4 Division of Infection and Immunity, University College London, London WC1E 6JF, United Kingdom. 5 Department of Infection Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom; martin.goodier@lshtm.ac.uk.

[h=3]Abstract[/h] Cytokine-induced memory-like (CIML) NK cells generated in response to proinflammatory cytokines in vitro and in vivo can also be generated by vaccination, exhibiting heightened responses to cytokine stimulation months after their initial induction. Our previous study demonstrated that in vitro human NK cell responses to inactivated influenza virus were also indirectly augmented by very low doses of IL-15, which increased induction of myeloid cell-derived cytokine secretion. These findings led us to hypothesize that IL-15 stimulation could reveal a similar effect for active influenza vaccination and influence CIML NK cell effector functions. In this study, 51 healthy adults were vaccinated with seasonal influenza vaccine, and PBMC were collected before and up to 30 d after vaccination. Myeloid and lymphoid cell cytokine secretion was measured after in vitro PBMC restimulation with low-dose IL-15, alone or in combination with inactivated H3N2 virus; the associated NK cell response was assessed by flow cytometry. PBMC collected 30 d postvaccination showed heightened cytokine production in response to IL-15 compared with PBMC collected at baseline; these responses were further enhanced when IL-15 was combined with H3N2. NK cell activation in response to IL-15 alone (CD25) and H3N2 plus IL-15 (CD25 and IFN-γ) was enhanced postvaccination. We also observed proliferation of less-differentiated NK cells with downregulation of cytokine receptors as early as 3 d after vaccination, suggesting cytokine stimulation in vivo. We conclude that vaccination-induced "training" of accessory cells combines with the generation of CIML NK cells to enhance the overall NK cell response postvaccination.
Copyright ? 2019 by The American Association of Immunologists, Inc.


PMID: 31427444 DOI: 10.4049/jimmunol.1801648
 
Back
Top Bottom